Second, in humans, ATP13A2 mutations cause neurodegeneration with brain iron accumulation45; in particular, KRS patients present iron deposits in the brain45,46 whereas, in mammalian cells, ATP13A2 expression and transport activity protect against several heavy metals, such as manganese, zinc, and iron toxicity43,76. This evidence concerns the gene ATP13A2 and Kufor-Rakeb syndrome.